Jazz Pharmaceuticals plc buy Truist Financial Co.
Start price
20.03.24
/
50%
€115.00
Target price
20.03.25
€184.14
Performance (%)
-11.04%
Price
26.04.24
€102.30
Summary
This prediction is currently active. The prediction for Jazz Pharmaceuticals plc disappoints with a performance of -11.04%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | -0.872% | -0.872% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $200.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€112.25
04.12.23
04.12.23
€184.92
04.12.24
04.12.24
-9.67%
26.04.24
26.04.24